Advanced Cell Technology, Inc., applying proprietary human embryonic stem (ES) cell technology to the emerging field of regenerative medicine, today announced that it has retained Burrill & Company, a specialty merchant bank with expertise in biotechnology and related fields, to act as its financial advisor with regard to the formation of strategic partnerships designed to accelerate development of stem cell based cures and treatments.
Advanced Cell Technology is actively seeking corporate partners in regard to its proprietary technology and therapeutic development programs. Specifically, the Company plans to find development partners for its retinal, hemangioblast and dermal programs as it proceeds into human clinical trials.
Burrill & Company is a boutique merchant bank specializing in the life sciences industry that brings strong expertise in forming and optimizing strategic partnerships, especially in the international marketplace.
"We are excited to be working with the entire Burrill Team,"Â said William M. Caldwell IV, Chairman and CEO of Advanced Cell Technology. "Burrill & Company brings a new level of expertise and focus to our corporate partnering efforts and I believe their firm will be instrumental in assisting us to fulfill our corporate partnering milestone."Â
Burrill & Company is a life sciences merchant bank focused exclusively on companies involved in biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies, nutraceuticals and wellness, agricultural biotechnology, and industrial biotechnology (biomaterials/bioprocesses) with over $850 million under management - Advanced Cell Technology.
Posted January 24th, 2007 by Nymphadora
